Workflow
上海莱士
icon
Search documents
上海莱士:截至2026年1月30日公司股东总户数为115163户
Zheng Quan Ri Bao Wang· 2026-02-09 13:40
Group 1 - The core point of the article is that Shanghai Laishi (002252) reported a total of 115,163 shareholders as of January 30, 2026 [1]
海尔最强独角兽冲击 IPO,6 成收入靠“啃老”
Sou Hu Cai Jing· 2026-02-06 20:15
Core Viewpoint - Haier Group's ecological layout is facing a significant test as its industrial internet subsidiary, Kaos, has submitted an IPO application to the Hong Kong Stock Exchange, marking a critical moment for the company's strategic transformation and its leadership transition [2][3]. Group 1: Haier's Strategic Moves - Haier has aggressively pursued capital market ambitions, acquiring major stakes in companies like Shanghai Laishi and Auto Home, and currently holds interests in eight listed companies, forming a robust "ecological empire" [3]. - The complexity of Haier's diversified ecosystem raises questions about the actual market competitiveness of its subsidiaries versus their reliance on the group's support [4]. Group 2: Kaos's Business Model and Performance - Kaos offers a combination of digital operating systems, AI, and IoT devices, serving over 160,000 enterprises, with a market share of 1.2% in China's industrial data intelligence solutions market [5]. - Despite generating approximately 5 billion in revenue from 2023 to 2025, Kaos has struggled with profitability, reporting a net loss of 82.72 million in 2023 and a net profit margin of only 1.3% in 2024 [6][7]. - The company's low gross margin, hovering around 17.8% to 18%, is attributed to an imbalanced business structure, with the more profitable data intelligence solutions accounting for only 18.3% of revenue in 2023 [8][9]. Group 3: Revenue Dependency and Risks - A significant portion of Kaos's revenue comes from related party transactions, with over 80% of its income derived from its top five clients, primarily Haier itself, raising concerns about its independence and sustainability [10]. - The performance of Kaos in the capital market will largely depend on Haier's core business, which remains focused on home appliances [11]. Group 4: Haier's Core Business Challenges - Haier's home appliance segment, particularly its traditional products, is showing signs of fatigue, with growth rates lagging behind the overall market [12][15]. - In the first three quarters of 2025, Haier's revenue reached 234.05 billion, with a net profit of 17.37 billion, but its net profit margin of 7.4% is the lowest among its major competitors [18][20]. Group 5: Financial Health and Management Issues - Haier's high sales expense ratio of 10.6% compared to its competitors indicates potential inefficiencies in cost management [20]. - The increase in accounts receivable turnover days suggests that Haier may be extending credit terms to maintain revenue growth, which could pose risks in cash flow management [22]. Group 6: Diversification and Future Outlook - Haier's aggressive diversification strategy has led to significant goodwill on its balance sheet, with goodwill amounting to 27.6 billion, raising concerns about potential impairments if acquisitions do not meet performance expectations [25][26]. - The company's recent regulatory issues in its financial services division highlight the reputational risks associated with its rapid expansion [27][28]. - As Haier pushes for more assets to be listed in the capital market, the sustainability of its ecological narrative and the profitability of its subsidiaries remain in question [29][32].
“海尔系”资本列车再提速 卡奥斯与海尔新能源联袂冲刺IPO
Core Viewpoint - Haier Group is accelerating its capital expansion with plans for IPOs of its subsidiaries, including the industrial internet platform Kaos and Haier New Energy, potentially increasing its total market value to over 350 billion yuan [1][5]. Group 1: IPO Developments - Kaos submitted its IPO application to the Hong Kong Stock Exchange on January 30, 2026, becoming a highly anticipated industrial technology IPO project [1]. - Haier New Energy has completed its listing counseling and is preparing for its IPO after a successful financing round exceeding 1 billion yuan [3][4]. Group 2: Business Performance - Kaos has over 9,500 paying customers and ranks first in China's market for platform-based industrial data intelligence solutions, with a revenue of 4.421 billion yuan for the first nine months of 2025, a 21.62% increase year-on-year [2]. - The revenue from Kaos's data intelligence solutions reached approximately 1.149 billion yuan in 2024, growing by about 25.9%, and 1.28 billion yuan in the first nine months of 2025, a 59.6% increase [2]. Group 3: Global Expansion - Kaos's international revenue reached approximately 709 million yuan in 2024, with solutions deployed in over 20 countries and serving more than 50 overseas enterprises [3]. - The company has empowered 17 lighthouse factories globally, establishing the largest and most diverse "lighthouse cluster" [3]. Group 4: Strategic Vision - Haier Group aims to create a sustainable ecosystem through its three main sectors: smart home, digital economy, and health, focusing on continuous innovation and adaptability [6]. - The expansion of the "Haier system" is not merely a top-down strategy but a result of internal organizational reforms to enhance creativity and value generation [6].
分红早知道|最近72小时内,华信新材、方正证券、古井贡酒、安孚科技、兴业银行等6家A股上市公司发布分红派息实施公告!
Mei Ri Jing Ji Xin Wen· 2026-02-02 07:06
Group 1: Dividend Indices - The Low Volatility Dividend Index (H30269.CSI) includes 50 securities with good liquidity, continuous dividends, moderate payout ratios, positive growth in dividends per share, high dividend yields, and low volatility, with a dividend yield of 4.53% as of January 30 [1] - The Quality Dividend Index (931468.CSI) consists of 50 securities that provide continuous cash dividends, have high payout ratios, and exhibit high profitability, with a dividend yield of 2.88% as of January 30 [1] Group 2: Company Dividend Announcements - Huaxin New Materials announced a cash dividend of 1 yuan per 10 shares (tax included), with a record date of February 5, 2026, and an ex-dividend date of February 6, 2026 [1] - Founder Securities declared a cash dividend of 0.01 yuan per share (tax included), with a record date of February 5, 2026, and an ex-dividend date of February 6, 2026 [2] - Anhui Anfu Battery Technology announced a cash dividend of 0.12 yuan per share (tax included), with a record date of February 5, 2026, and an ex-dividend date of February 6, 2026 [2] - Gujing Gongjiu declared a cash dividend of 10 yuan per 10 shares (tax included), with a record date of February 9, 2026, and an ex-dividend date of February 10, 2026 [2] - Shanghai Laishi announced a cash dividend of 0.153 yuan per 10 shares (tax included), with a record date of February 9, 2026, and an ex-dividend date of February 10, 2026 [3] - Industrial Bank declared a cash dividend of 0.565 yuan per share (tax included), with a record date of February 5, 2026, and an ex-dividend date of February 6, 2026 [3]
我们的2025 | 申万宏源大投行业务全景回顾
编者荐语: 转载自申万宏源发布。 以下文章来源于申万宏源发布 ,作者申万宏源证券 申万宏源发布 . 申万宏源证券官方发布 6 中资离岸债承销数量排名中资券商 第5 + 服务科技金融 + 聚焦创新驱动,点燃科技引擎 i 服务科技领域境内股权融资17单、募集资金 规模70.88亿元,同比大幅增长 9 发行科技创新债券142只、规模522.99亿元, 同比分别增长167.92%和161.58% ✪ 「申万宏源大投行业务全景回顾」 2025年,是全面完成"十四五"规划目标的"收 官之年",申万宏源大投行业务深化科技化、产 业化、国际化、一体化的转型发展方向,坚守功 能性定位,构筑服务国家战略新生态。 数说2025: 以金融之力 赋能局质量发展大局 新三板累计挂牌家数、定向发行次数保持行业 e 第1 2 A股IPO发行上市5单,排名 1;其中创业 板3单,排名第3 并购重组财务顾问交易规模1,392亿元,排名 B 算3 债券主承销债券923只、金额3.545亿元,稳居 S 行业第一梯队,其中熊猫债(国际机构债)承销 只数排名第3,金融债承销只数排名并与 港股IPO保荐数量、承销数量均排名中资券商 5 IPO 助力科技领 ...
上海莱士血液制品股份有限公司2025年前三季度权益分派实施公告
Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. has announced its profit distribution plan for the first three quarters of 2025, which includes a cash dividend of 0.153 RMB per 10 shares for all shareholders, excluding shares held in the company's repurchase account [2][3][7]. Group 1: Profit Distribution Plan - The profit distribution plan was approved at the third extraordinary general meeting of shareholders held on December 15, 2025 [3][5]. - The cash dividend will be distributed based on the total share capital excluding the 69,081,952 shares held in the repurchase account, resulting in a total of 6,568,902,885 shares eligible for the dividend [2][7]. - The total cash dividend amount is calculated to be 100,504,214.14 RMB, with an adjusted per-share dividend of 0.0151407 RMB [2][11]. Group 2: Dividend Payment Details - The record date for the dividend distribution is set for February 9, 2026, and the ex-dividend date is February 10, 2026 [7][8]. - Cash dividends will be directly credited to shareholders' accounts through their securities companies on the ex-dividend date [9]. - The company will not issue bonus shares or convert reserves into share capital as part of this distribution [4][5]. Group 3: Tax Implications - Different tax rates will apply to various categories of shareholders, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [7]. - The tax implications for individual shareholders will depend on their holding period, with specific amounts to be paid based on the duration of their shareholding [7].
卡奥斯赴港IPO!海尔系资本布局“加速跑”
Xin Lang Cai Jing· 2026-02-01 12:49
Core Viewpoint - The "Haier system" is rapidly expanding its capital footprint, with Kaos IoT Technology Co., Ltd. submitting its application for an IPO on the Hong Kong Stock Exchange, following Haier New Energy's A-share listing guidance [1][11] Group 1: Company Performance - Kaos reported steady revenue growth, achieving approximately CNY 4.994 billion in 2023 and CNY 5.069 billion in 2024, with a net profit turnaround from a loss of CNY 82.72 million in 2023 to a profit of CNY 65.14 million in 2024 [3][13] - For the first three quarters of 2025, Kaos generated approximately CNY 4.421 billion in revenue, up from CNY 3.635 billion in the same period the previous year, with a profit of approximately CNY 176 million, significantly higher than the CNY 35.71 million from the previous year [3][13] Group 2: Dependency on Haier Group - Haier Group is the largest customer of Kaos, contributing over 57.7% of the company's revenue in the first three quarters of 2025, with sales to Haier amounting to CNY 2.549 billion [4][14] - The proportion of sales to the top five customers was approximately 69.7% in 2025, with Haier's contribution being CNY 3.607 billion in 2023, CNY 3.421 billion in 2024, and CNY 2.549 billion in 2025 [4][14] Group 3: Market Position and Strategy - Kaos is positioned as a leading provider of industrial data intelligence solutions in China, ranking first in the market based on platform revenue for 2024 [2][12] - The decision to pursue a listing on the Hong Kong Stock Exchange follows challenges faced in attempting to list on the STAR Market, where regulatory scrutiny and lengthy approval processes were significant factors [2][12] Group 4: Capital Expansion - The Haier Group has established a capital structure that spans both A-share and H-share markets, currently comprising eight listed entities, with the potential to increase to ten if both Kaos and Haier New Energy successfully complete their IPOs [1][11][18] - The total market capitalization of Haier's listed companies exceeds CNY 330 billion, with Haier Smart Home leading at CNY 235.472 billion [17][18]
冲击IPO!卡奥斯递表港交所,海尔系资本布局“加速跑”
Bei Jing Shang Bao· 2026-02-01 12:14
Core Viewpoint - The Haier Group is expanding its capital footprint with the recent IPO applications of its subsidiaries, Kaos and Haier New Energy, aiming to increase the number of listed companies under its umbrella to ten if both IPOs are successful [1][12]. Group 1: Company Performance - Kaos has shown steady performance improvement, with revenues of approximately RMB 4.994 billion in 2023 and RMB 5.069 billion in 2024, and a projected net profit turnaround from a loss of RMB 82.72 million in 2023 to a profit of RMB 65.14 million in 2024 [4]. - For the first three quarters of 2025, Kaos reported revenues of about RMB 4.421 billion, up from RMB 3.635 billion in the same period the previous year, with a corresponding profit of approximately RMB 176 million, significantly higher than the RMB 35.71 million from the previous year [4]. Group 2: Dependency on Haier Group - Haier Group is the largest customer of Kaos, contributing 57.7% of its revenue in the first three quarters of 2025, with sales to Haier amounting to RMB 25.49 billion [6]. - The sales to the top five customers accounted for approximately 69.7% of Kaos's revenue in the same period, indicating a high dependency on a limited customer base [6]. Group 3: Market Position and Strategy - Kaos is positioned as a leading provider of industrial data intelligence solutions in China, ranking first in the market based on projected revenue for 2024 [3]. - The decision to pursue a listing on the Hong Kong Stock Exchange instead of the Sci-Tech Innovation Board is seen as a strategic move to avoid stringent regulatory pressures associated with the latter [3][4]. Group 4: Capital Expansion - The Haier Group has established a capital structure that spans both A-share and H-share markets, currently comprising eight listed companies with a total market value exceeding RMB 330 billion [9]. - If Kaos and Haier New Energy successfully complete their IPOs, the number of listed companies under Haier Group will increase to ten, further solidifying its market presence [12].
上海莱士(002252) - 2025年前三季度权益分派实施公告
2026-02-01 07:45
证券代码:002252 证券简称:上海莱士 公告编号:2026-002 上海莱士血液制品股份有限公司 2025 年前三季度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 特别提示: 1、根据《公司法》《深圳证券交易所上市公司自律监管指引第9号——回购 股份》等相关规定,公司通过回购专用证券账户持有的本公司股份69,081,952股 不享有参与本次权益分派的权利。公司2025年度1~9月权益分派方案为:以分红 派息股权登记日总股本(扣除公司回购专用证券账户持有公司股票)为基数,向 全体股东每10股派发现金股利0.153元人民币(含税),本次利润分配公司不送 红股,不以公积金转增股本。 2、本次权益分派实施后,按公司总股本折算每10股现金分红比例及除权除 息参考价如下:考虑到公司回购专用证券账户上的股份不参与2025前三季度权益 分派,公司本次实际现金分红的总金额=实际参与分配的总股本*分配比例= 6,568,902,885股*0.0153元/股=100,504,214.14元;折算每10股现金红利=本次实际 现金分红的总金额÷总股本(含公司回购 ...
上海莱士:人纤维蛋白原获得《药品注册证书》
Ge Long Hui· 2026-01-30 10:11
Core Viewpoint - Shanghai Raas (002252.SZ) announced that its wholly-owned subsidiary, Tonglu Biopharmaceutical Co., Ltd., has recently received a Drug Registration Certificate from the National Medical Products Administration for its product, Human Fibrinogen [1] Company Summary - Tonglu Biopharmaceutical's product, Human Fibrinogen, is derived from healthy human plasma, which is isolated, purified, and treated for virus removal and inactivation before being freeze-dried [1] - The indication for this product is congenital fibrinogen deficiency or reduction [1]